Pharmacokinetics of synthadotin (ILX651), a novel tubulin polymerization inhibitor, in patients with solid tumorsPeter L. Bonate, L. A. Hammond, Eric H. Rubin et al.|Journal of Clinical Oncology|2004Cited by 2
Pharmacokinetics of synthadotin (ILX651), a novel tubulin polymerization inhibitor, in patients with solid tumorsPeter L. Bonate, L. A. Hammond, Scot Ebbinghaus et al.|Journal of Clinical Oncology|2004Cited by 0